On Worlds AIDS Day (December 1), the U.S. Food and Drug Administration (FDA) announced that it proposes to not only reclassify the female condom from a Class III to a Class II medical device, but to also de-gender the device through renaming it the “single-use internal condom.” The proposed order also calls for expanding the indication […]

Go to Original Post